Results 181 to 190 of about 10,309 (223)

Antenatal risk estimation for exchange transfusions in neonates with hemolytic disease of the fetus and newborn in a changing treatment landscape: A multicenter, retrospective cohort study. [PDF]

Transfusion
de Winter DP, de Haas M, Hulzebos CV, Lukens MV, Prins SA, Been JV, d'Haens EJ, Vijlbrief DC, Vrancken SLAG, Trompenaars AMP, Ceelie H, van Zogchel LMJ, Joosen AMCP, Meijssen CB, van Hillegersberg JLAM, Zant JC, van Rossem MC, van Beek R, Stas HG, Counsilman CE, Knol FR, Schiering IAM, Dubbink-Verheij GH, Verweij EJT, Lopriore E, WISE investigators.   +25 more
europepmc   +1 more source

Challenges and limitations of mobilization and stem cell collection for gene therapy of sickle cell disease. [PDF]

Blood Adv
Tanhehco YC, Thibodeaux S, Shi PA, Chou ST, Kelly SA, Monis GF, Newton C, West-Mitchell K, Zheng Y, Fernandez C, Anderson C, Ching K, Coleman-Cowger V, Shapiro A, Manis JP.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Alloimmune Thrombocytopenia

Clinical Obstetrics and Gynecology, 1999
For the fetuses who are at risk for antenatal or postnatal sequelae from AIT, prevention and treatment are now possible. This requires the attention of the obstetrician to factors in the patient's history and early referral to a center experienced in the diagnosis and management of fetal AIT.
D W, Skupski, J B, Bussel
openaire   +2 more sources

Alloimmune Neonatal Neutropenia

Journal of Pediatric Hematology/Oncology, 1991
In three neonates, the diagnosis of anti-NA1 alloimmune neutropenia related to maternal immunization against fetal polymorphonuclear leukocytes (PMN) antigens was achieved by serum antibody screening and PMN phenotyping. All the children were small for date and exhibited bacterial infection within days 2-13. Neutropenia persisted until days 20-50. High-
J, Cartron, G, Tchernia, J L, Celton, M, Damay, G, Cheron, P, Farrokhi, J, Badoual   +6 more
openaire   +2 more sources

Neonatal Alloimmune Amegakaryocytosis

Vox Sanguinis, 1988
Abstract. A case of neonatal alloimmune thrombocytopenia with amegakaryocytosis is described. The baby was treated by double‐volume exchange transfusion with only a temporary benefit; 2 weeks of steroid treatment were unsuccessful but the platelet count did increase transiently after infusion of random donor platelets.
Nicola Bizzaro, Gianfranco Dianese
openaire   +1 more source

Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness

Transfusion Medicine Reviews, 2020
Despite significant advancements in the production of platelet products, storage, and transfusion, transfusion refractoriness remains a significant clinical problem, affecting up to 14% of hematological patients receiving platelet transfusions. Human leukocyte antigen (HLA) alloimmunization is a major cause of immune platelet refractoriness, and its ...
Anno, Saris, Katerina, Pavenski
openaire   +2 more sources